Stay updated on Combination Therapy in Metastatic Pancreatic Ductal Adenocarcinoma Clinical Trial
Sign up to get notified when there's something new on the Combination Therapy in Metastatic Pancreatic Ductal Adenocarcinoma Clinical Trial page.

Latest updates to the Combination Therapy in Metastatic Pancreatic Ductal Adenocarcinoma Clinical Trial page
- CheckyesterdayChange DetectedClinicalTrials.gov’s page interface shows an updated software revision in the footer (from v3.5.2 to v3.5.3). This reflects a site/update version change rather than any modification to the trial record text.SummaryDifference0.0%

- Check8 days agoChange DetectedAdded a new revision entry: Revision: v3.5.2 and removed Revision: v3.5.0.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check36 days agoChange DetectedRevision history updated to add Revision: v3.5.0 and remove Revision: v3.4.3.SummaryDifference0.0%

- Check51 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed on the Record History page.SummaryDifference0.0%

- Check72 days agoChange DetectedFooter revision updated from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check79 days agoChange DetectedThe Record History page shows a minor metadata update: a new Revision: v3.4.1 is added while the previous v3.4.0 entry is removed. This change does not affect study data, eligibility criteria, interventions, outcomes, or timelines. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

Stay in the know with updates to Combination Therapy in Metastatic Pancreatic Ductal Adenocarcinoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combination Therapy in Metastatic Pancreatic Ductal Adenocarcinoma Clinical Trial page.